Good Chemistry Inc., a leading computational chemistry company, leverages AI, quantum and other advanced technologies to accelerate drug discovery and materials design.
Good Chemistry Inc. was acquired by a subsidiary of SandboxAQ by way of a plan of arrangement.
Fasken advised Good Chemistry Inc. with a team led by Geoff Pedlow (M&A), and included Karam Bayrakal (Corporate/Commercial), Gary Ott (Corporate/Commercial), Katie Peardon, (Corporate/Commercial), Reina Mistry (Corporate/Commercial), Brock Euper (Corporate/Commercial), Michael Coburn (Tax) and Christopher Ross (Tax).
Jurisdiction
- British Columbia
